These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22278738)

  • 21. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice.
    Lam HYP; Liang TR; Lan YC; Chang KC; Cheng PC; Peng SY
    J Microbiol Immunol Infect; 2022 Apr; 55(2):314-322. PubMed ID: 34167886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive CTLA-4-Ig Treatment Reduces Hepatic Egg Load and Hepatic Fibrosis in
    Sombetzki M; Rabes A; Bischofsberger M; Winkelmann F; Koslowski N; Schulz C; Reisinger EC
    Biomed Res Int; 2019; 2019():1704238. PubMed ID: 31950032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Praziquantel Treatment of
    Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
    Front Immunol; 2021; 12():748387. PubMed ID: 34956183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.
    Manneck T; Haggenmüller Y; Keiser J
    Parasitology; 2010 Jan; 137(1):85-98. PubMed ID: 19814844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
    Mohamed AH; Osman GY; Salem TA; Elmalawany AM
    Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
    Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; Megahed N
    Parasitol Int; 2017 Oct; 66(5):545-554. PubMed ID: 28408356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection.
    Koslowski N; Sombetzki M; Loebermann M; Engelmann R; Grabow N; Österreicher CH; Trauner M; Mueller-Hilke B; Reisinger EC
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005595. PubMed ID: 28542175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress.
    Al-Olayan EM; El-Khadragy MF; Alajmi RA; Othman MS; Bauomy AA; Ibrahim SR; Abdel Moneim AE
    BMC Complement Altern Med; 2016 Nov; 16(1):434. PubMed ID: 27821159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.
    Abdel-Hafeez EH; Ahmad AK; Abdulla AM; Aabdel-Wahab S; Mosalem FA
    Parasitol Res; 2012 Aug; 111(2):577-86. PubMed ID: 22398831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
    Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
    Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy.
    Gassiep I; Clark PJ; McManus DP; Looke DL
    J Gastroenterol Hepatol; 2016 May; 31(5):910. PubMed ID: 26598933
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
    el-Badrawy NM; Hassanein HI; Botros SS; Nagy FM; Abdallah NM; Herbage D
    Exp Mol Pathol; 1988 Oct; 49(2):151-60. PubMed ID: 3139442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.
    Farah IO; Mola PW; Kariuki TM; Nyindo M; Blanton RE; King CL
    J Immunol; 2000 May; 164(10):5337-43. PubMed ID: 10799896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.